https://www.selleckchem.com/pr....oducts/resatorvid.ht
INTRODUCTION A comprehensive characterisation of the tumour microenvironment is lacking in neuroendocrine tumours (NETs), where programmed cell death-1 receptor-ligand (PD-1/PD-L1) inhibitors are undergoing efficacy testing. OBJECTIVE We investigated drivers of cancer-related immunosuppression across NETs of various sites and grade using multi-parameter immunohistochemistry and targeted transcriptomic profiling. METHODS Tissue microarrays (n=102) were stained for PD-L1 2, Indoleamine-deoxygenase-1 (IDO-1) and evaluated in relat
Like
Comment
Share
